Devyser Diagnostics
Develops & sells genetic DNA test kits for labs in oncology, transplant & reproductive health.
DVYSR | ST
Overview
Corporate Details
- ISIN(s):
- SE0016588867 (+1 more)
- LEI:
- 549300RV4Z2K3360CK30
- Country:
- Sweden
- Address:
- Instrumentvägen 19, 126 53 Hägersten
- Website:
- https://devyser.com/
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
Devyser Diagnostics is a company specializing in the development, manufacture, and sale of advanced diagnostic kits for genetic DNA testing. Serving clinical laboratories, its product portfolio addresses critical areas such as reproductive health, oncology for guiding targeted cancer therapies, and post-transplant monitoring. Devyser's core mission is to simplify and streamline complex laboratory workflows by providing fast, accurate, and user-friendly solutions. The company's end-to-end tests are designed to significantly reduce sample-to-result times and manual handling, aiming to enhance laboratory efficiency, enable quicker patient diagnoses, and advance the accessibility of personalized medicine.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all Devyser Diagnostics filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Devyser Diagnostics
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Devyser Diagnostics via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2025-03-14 | Mia Arnhult | Other | Buy | 7,000 | 745,290.00 SEK |
